FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Terazosin hydrochloride from Jubilant Cadista Pharmaceuticals, resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• Terazosin (terazosin)

Snippet

SUPPL AP for TERAZOSIN (TERAZOSIN HYDROCHLORIDE)